Clinical Trials
35 trialsSentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery
Başakşehir Çam & Sakura City Hospital
LETSGO
Sorlandet Hospital HF
EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection
Queensland Centre for Gynaecological Cancer
PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer
N.N. Alexandrov National Cancer Centre
FOCUS / KOV-04
National Cancer Center, Korea
KOV-HIPEC-02R
National Cancer Center, Korea
Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life
Taipei Veterans General Hospital, Taiwan
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
Shanghai Gynecologic Oncology Group
KOV-02S
National Cancer Center, Korea
NEURO-GLOVE
Ankara Etlik City Hospital
ICRA
NHS Grampian
OC-POP-PT
Tel-Aviv Sourasky Medical Center
Surgery for Relapsed Ovarian Cancer in Precision
Shanghai Gynecologic Oncology Group
Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery
Sheikh Zayed Medical College
SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
Shanghai Gynecologic Oncology Group
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
Shanghai Gynecologic Oncology Group
DECIDER
Turku University Hospital
A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.
Fujian Cancer Hospital
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Sheba Medical Center
Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
Fujian Cancer Hospital
Role of Laparoscopy in Assessing Resectability of Ovarian Cancer
Zagazig University
Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
Shanghai Gynecologic Oncology Group
Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2
Vastra Gotaland Region
BEDOCA
Sheba Medical Center
Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer
Henan Cancer Hospital
Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian
Sheba Medical Center
Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
Anhui Provincial Hospital
AICE
Shanghai Gynecologic Oncology Group
Total/Subtotal Colectomy in Ovarian Cancer
Shanghai Gynecologic Oncology Group
ICON6
Medical Research Council
Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies
Sheba Medical Center
OPEN
Queensland Centre for Gynaecological Cancer
ICON8
Medical Research Council
Hydralazine Valproate for Ovarian Cancer
National Institute of Cancerología